Suen, Yi Nam
Lee, Edwin Ho Ming
Lam, Christina Oi Bun
Hui, Christy Lai Ming
Chan, Sherry Kit Wa
Chang, Wing Chung
Chen, Eric Yu Hai
Article History
Received: 28 January 2023
Accepted: 25 May 2023
First Online: 31 May 2023
Declarations
:
: The study protocol was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster. The study was conducted according to the relevant guidelines and regulations. For participation in the current evaluation study, the participants were required to provide informed written consent.
: Not applicable.
: EYHC reports having received speaker honoraria from Otsuka and DSK BioPharma; received research funding from Otsuka; participated in paid advisory boards for Janssen and DSK BioPharma; received funding to attend conferences from Otsuka and DSK BioPharma. The remaining authors declare no competing interests.